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Lipid alterations induced by renal ischemia: Pathogenic factor in mem-
brane damage. Lipids of the renal cortex and outer stripe of outer me-
dulla were analyzed in rats during ischemia and 2 hr after blood re-
flow. After 15 mm of ischemia, there were marked elevations of free
fatty acids (FFA) and diacylglycerol (DG), increasing further at 60 mm.
Percentile increases were greater for polyunsaturated FFA. These el-
evations were accompanied by alterations in phospholipids (PL): El-
evations of lysophosphatidylcholine (LPC) at 15 mm, phosphatidic acid
at 15 and 60 mm, and declines of phosphatidylcholine and phosphati-
dylinositol at 60 mm. Triacylglycerol (TG) showed only modest de-
cline, at 60 mm, and in insufficient degree to account for increments in
FFA and DG. Two hours after 15 mm of ischemia, LPC returned to
control levels and other PL were normal except phosphatidylinositol
which was decreased, and phosphatidic acid, which remained el-
evated. FFA and DG approached or reached control values. Two hours
after 60 mm of ischemia, LPC, FFA, DGs and phosphatidic acid re-
mained elevated: phosphatidyicholine and phosphatidylinositol re-
mained decreased. Histological injury was seen 2 and 24 hr after blood
reflow only in kidneys injured by 60 mm of ischemia. Thus, irrevers-
ible ischemic damage correlates with persistent abnormalities of
phosphatidyicholine metabolism and persistent elevations of FFA,
LPC, and DG. It is not known whether lipids break down at normal or
accelerated rates during ischemia. In this context, accumulation of
lipid breakdown products in ischemic cells may be due to failure of
their reutilization, or disposal. Similarly, depletion of phospholipids
during ischemia may be due to the inability of cells to reconstitute the
lipid following degradation. Regardless of the mechanism, the deple-
tion of phospholipids and accumulation of lipid breakdown products
which occur during ischemia may be responsible for membrane dam-
age. In partial agreement with this view, the addition of unesterified,
unsaturated fatty acids to primary cultures of proximal tubule cells was
shown to result in plasma membrane blebbing and cell death.
Alterations lipidiques induites par l'ischémie rénale: Un facteur
pathogene pour les lesions membranaires. Les lipides de Ia corticale et
de La couche externe de Ia médullaire externe rénales ont été analyses
chez des rats au cours d'une ischémie, et 2 heures aprês recirculation
sanguine. Après 15 minutes d'ischémie, il existait des ëlévations
marquees des acides gras libres (FFA) et du diacylglycerol (DG), qui
augmentaient encore a 60 minutes. Les elevations en pourcentage
étaient plus fortes pour les FFA polyinsatures. Ces elevations
s'accompagnaient d'altérations des phospholipides (PL): augmentation
de Ia lysophosphatidylcholine (LCP) a 15 minutes, de l'acide phospha-
tidique a 15 et 60 minutes, et baisses de Ia phosphatidylcholine et du
phosphatidylinositol a 60 minutes. Le triacylglycerol (TG) diminuait
seulement modérément a 60 minutes, et de facon insuffisante pour re-
ndre compte des élévations de FFA et de DG. Deux heures après IS
minutes d'ischémie, LPC est retournée aux niveaux contrôles, et les
autres PL étaient normaux a l'exception du phosphatidylinositol qui
était diminué, et de l'acide phosphatidique qui restait Clevé. Les FFA
et DG approchaient ou atteignaient les valeurs contrôles. Deux heures
après 60 minutes d'ischémie, les LPC, FFA, DGs et l'acide phospha-
tidique reslaient elevés; Ia phosphatidylcholine et Ic phosphatidylino-
sitol restaient bas. Des lesions histologiques ont été observées au bout
de 2 et 24 heures aprCs recirculation sanguine uniquement dans les
reins alteres par 60 minutes d'ischémie. Ainsi, une atteinte ischemique
irreversible est corrélCe a des anomalies persistantes du metabolisme
de la phosphatidylcholine, et a des élévations persistantes des FFA,
LPC, et DG. On ne sait pas si les lipides se dCgradent a des vitesses
normales ou élevées au cours de I'ischémie. Dans ce contexte,
l'accumulation de produits de degradation des lipides dans les cellules
ischemiques pourrait résulter d'un trouble de leur réutilisation ou de
leur elimination. De méme, Ia déplétion en phospholipides lors de
l'ischemie pourrait rCsulter d'une incapacité des cellules a reconstituer
les lipides après leur degradation. Quel qu'en soit le mCcanisme, Ia
depletion en phospholipides et l'accumulation de produits de
degradation des lipides qui surviennent pendant l'ischémie pourraient
être responsables d'une alteration membranaire. En accord partiel avec
cette idée. l'addition des les acides gras non esterifles et non saturés a
les cultures primaires des cellules tubulaires proximales a etC montrC
resulter dans de bulles dans Ia membrane plasmique et Ia mort des
cellules.
Nephron obstruction and altered epithelial permeability are
major pathogenetic factors in ischemic acute renal failure. Is-
chemia-induced membrane damage, particularly in the proxi-
mal tubule brush border, can account for both. Although these
structural events have been adequately documented, the bio-
chemical basis for the membrane defect remains unexplained.
Recent studies suggest that renal cortical choline phospholip-
ids, particularly in proximal tubule brushborder microvilli, are
synthesized at an accelerated rate during the period of blood
reflow following renal artery clamping [1, 2]. In the course of
investigations on hormone selective arachidonate deacylation
in hydronephrotic kidneys, it was observed that short periods
of ischemia (5 mm) caused deacylation of arachidonic acid
from prelabelled renal cortical phospholipids [31. Biochemical
studies on ischemic heart, brain, and liver suggest the occur-
rence of altered lipid metabolism, which may relate to altered
membrane structure and function [3—I 1]. Because renal anoxic
injury is characterized by marked membrane damage [12—161,
possibly caused by alterations in membrane lipids, we have in-
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vestigated in detail these changes in the arterial occlusion
model of renal ischemia.
Methods
Studies were performed on male Sprague-Dawley rats that
weighed 280 to 320 g and were put on a standard rat chow with
free access to tap water until the time of experiments. After an-
esthesia with sodium pentobarbital (50 mg/kg body weight) was
administered, the right renal artery was clamped (Codman 19-
8092 clamp) for respectively 5, 15, or 60 mm, with or without
removal of the clamp to allow blood reflow for 120 mm. In the
rat, ischemic durations of 15 mm or less are attended by mor-
phological alterations that are entirely reversible; conversely,
60 mm of ischemia causes severe membrane dysfunction and
damage leading to necrosis of the proximal tubule [12]. At the
end of the ischemic period or after 2 hr of reflow, the kidney
was flushed with ice-cold Krebs-Henseleit bicarbonate buffer
(gassed with 95%, 02; 5% C02) via retrograde aortic cannula,
which was continued until the kidney was washed free of blood
(approximately 30 sec). The kidney was removed and the cor-
tex and outer stripe of the outer medulla were dissected on an
ice-cold plate. After being blotted free of excess buffer, sepa-
rate pieces were taken on tared plastic boats for determination
of wet weight and lipid extraction, or determination of wet and
dry weight. In separate studies, rat kidneys were rendered is-
chemic following a flushing of the vascular tree for 30 sec with
Krebs-Henseleit saline with or without 3% Ficoll (70,000
daltons) as oncotic agent. Kidneys were extracted for lipids ei-
ther immediately following washout of the vasculature or after
60 mm of ischemia.
Lipid extraction. Tissue lipids were extracted 2 x 15 mm
each with ice-cold solvents according to Bligh and Dyer [17],
using 2 M KC1 instead of water to phase the layers. The com-
bined chloroform layers were passed through a Sephadex G 25-
150 column, to remove impurities and water, and evaporated
under N2 at room temperature almost to dryness. The residue
was dissolved in 5 ml of CHCI3-methanol (1:1). After removal
of one aliquot for determination of total lipid phosphorus, the
extract was stored at —20°C overnight. Subsequent phospho-
lipid and neutral lipid separations were done within 24 hr.
Phospholipid phosphorus in lipid extract as well as in indi-
vidual spots on silica gel plates was measured according to
Rouser, Simon, and Kritchevsky [18]. For neutral lipid analy-
sis by thin layer chromatography (TLC), lipid extracts recon-
stituted in pure CHC13 were used as such, or after separation
from phospholipids by column chromatography on silicic acid-
Hyflo Supercel (2:1 W/W) [19].
Thin layer chromatography. Separation of phospholipids was
achieved by two-dimensional TLC on 0.25 mm Silica Gel plates
(Adsorbosil-5) or on 0.25 mm Silica Gel H. Solvents were
chloroform/methanol/acetic acid/water (65:25:2:4, vol/vol) and
chloroforml28% ammonialmethanol (77:5:30 vol/vol) in the first
and second dimensions, respectively. Phosphatidic acid was
isolated by one dimensional TLC on 0.25 mm Adsorbosil or
Silica Gel H with chioroform/pyridine/formic acid (20:12:2.8)
according to Farese, Sabir, and Larson [20]. Lysophosphatidic
acid was not separated. Spots were identified by co-chroma-
tography with known lipid standards and group specific stain-
ing procedures. After visualization with light iodine staining,
spots were scraped and phospholipid phosphorus were
determined.
Recoveries of known amounts of kidney phospholipids ap-
plied to thin layer plates were measured from spots separated
by thin layer chromatography and averaged 93% but was not
less than 85%. The values for lysophosphatidylcholine and
lysophosphatidylethanolamine (and other phospholipids) in
control, nonischemic kidneys were within the range previously
reported for rat kidneys [18]. Because acidic media were not
used for lipid extraction, conversion of plasmalogens to
lysophospholipids was considered not likely to occur. Because
acid treatment of thin layer plates (in between the first and sec-
ond dimensions, Horrocks' method [21]) was not used, con-
version of plasmalogens to the corresponding lysophospho-
lipids during TLC was also considered unlikely. In any event,
conversion of plasmalogens to lysophospholipids during thin
layer chromatography would result in the migration of the spu-
rious lysophospholipid to positions in the two-dimensional thin
layer chromatogram separate from authentic, native lysophos-
pholipid. Because only the spots that comigrated with authen-
tic lysophospholipid standards were sampled, we were sure
that intrapreparative conversion, if any, did not alter our
results.
Separation of neutral lipids was performed by one-dimen-
sional TLC on 0.25 mm Silica Gel plates using hexane/diethyl
ether/acetic acid (40:60:1 vol/vol) as solvent. Because triglycer-
ides moved close to cholesterol esters in this system, they were
separated using light petroleum ether/diethyl ether/acetic acid
(90:10:1 vol/vol). Identification was by co-chromatography
with known standards (triolein, 1 ,2-diolein, 1 ,3-diolein, hepta-
decanoic acid or arachidonic acid, monoolein and cholesterol)
in at least two different solvent systems. Further confirmation
of spots was based on chemical analysis for glycerol and gas
chromatography for fatty acids. Spots were visualized under
ultraviolet light after dichlorofluorescein spray. Glycerol analy-
sis in neutral lipid spots was by a modified chromotropic acid
colorimetric method [22].
Gas chromatography. For the analysis of triglycerides,
diglycerides, or free fatty acids, known amounts of trihepta-
decanoin, diheptadecanoin, or heptadecanoic acid (17:0) were
used respectively as internal standards prior to all separation
procedures to allow for recovery losses. Recoveries were at
least 90% and there were no significant differences in recover-
ies between individual fatty acids. Following TLC separation,
the tn- and diglyceride spots were scraped and treated with 0.5
N NaOH in methanol at 70 to 75°C for 1 hr, methylated with
14% BF3-methanol reagent. Prepared fatty acid methyl esters
(FAMES) were reconstituted finally into heptane. Free fatty
acid (FFA) spots were methylated directly.
To analyze the fatty acid composition of total phospholipid,
neutral lipids were separated from phospholipids by one-di-
mensional TLC (see above), and the origin containing phospho-
lipids was scraped and treated with 0.5 N NaOH in methanol
at 70 to 75°C for 1 hr. Fatty acids were esterified with 14% BF3
in methanol as described above. Gas liquid chromatography of
FAMES was done in a gas chromatograph (model 5700, Hew-
lett Packard, Elkhart, Indiana) using a 6 feet x 2 mm glass col-
umn packed with 10% SP-2330 on 100/120 Chromosorb WAW
(Supelco, Inc., Bellefonte, Pennsylvania). Fatty acid peak
identification was by measuring retention times using stan-
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dards, as well as by mass spectroscopic analysis (courtesy of
Dr. S. Weintraub, Departments of Pharmacology and Pathol-
ogy, University of Texas Health Science Center at San An-
tonio). For this investigation, only the following fatty acids
were analyzed: palmitic (16:0), stearic (18:0), oleic (18:1), ii-
noleic (18:2), arachidonic (20:4), and docosahexaenoic (22:6).
Other fatty acids constituted only a minor proportion of the to-
tal and no significant changes were measurable in their metabo-
lism. Results of chemical analyses are expressed as micro-
grams of lipid P, glycerol, FFA, triglyceride, fatty acid, or
diglyceride fatty acid per gram of dry weight of tissue. In our
experience, dry weight of tissue was a more reliable and re-
producible reference point than wet weight of tissue or tissue
protein, since the errors due to ischemia altered tissue water
content and protein content are minimized in the dry weight
determination.
Histological studies. In a separate group of 18 rats treated
similarly, right kidneys were made ischemic for 15 or 60 mm
and fixed for morphological studies at the end of the ischemic
period or after 2 and 24 hr of blood reflow. Fixation was by
vascular perfusion with 1.25% glutaraldehyde in 0.1 M sodium
cacodylate HC1 buffer pH 7.4. Tissue samples were subse-
quently transferred to 10% neutral buffered formalin for proc-
essing for light microscopic evaluation after the staining of par-
affin-embedded sections with hematoxylin and eosin.
Cytotoxicity of FFA. Proximal tubule fragments were iso-
lated from Sprague-Dawley rats weighing 150 to 250 g and
plated onto 25 mm glass coverslips in 35 mm plastic tissue cul-
ture dishes for explant growth of proximal tubule epithelial
cells using a previously described procedure [14]. The tissue
culture medium used was Roswell Park Memorial Institute me-
dium (RPMI) 1640 with 20% (v/v) fetal calf serum, penicillin,
streptomycin, and fungizone. Greater than 90% of the cells that
grow out from the explants can be identified as proximal tu-
bule cells by histochemical criteria [141. After 1 week of growth
in primary culture, the effect of added free fatty acids on mor-
phology and viability was determined. The fatty acids tested
were arachidonic (165, 82.5, and 33 tM; oleic (165 /LM); stearic
(165 LM); linoleic (165 /LM). Fatty acids were prepared as the
sodium salts in ethanol-water (1:4) by titration with 0.1 N
NaOH and added to the media at a final ethanol concentration
not exceeding 0.25%. Cultures were rinsed three times with
Ca+ + -Mg+ + free Hanks' Balanced Salt Solution to which
Mg++ was added back (Ca++ free HSS). Cells were exposed
to fatty acids or corresponding 0.25% ethanol controls in
Ca++ free HSS. The exposure medium was Ca++ free to
avoid the formation of insoluble calcium soaps of fatty acids.
In separate studies, the effect of albumin, included in the me-
dium together with arachidonic acid, was examined. Experi-
ments were done as above, with 82.5 ILM arachidonic acid, with
or without 130 M fatty acid free bovine serum albumin in the
incubation medium. Plasma membrane injury was determined
by examining the cells by phase contrast microscopy for bleb
formation [141 at 10 and 30 mm. Cell viability was determined
at 30 mm by trypan blue exclusion.
Statistical analysis. Differences between groups were ana-
lyzed by one-way analysis of variance and significance tested
by the Newman-Keuls and Duncan tests; where appropriate,
Student's t test was also used.
Chemicals and supplies. Lipid standards and column sup-
ports were purchased from Supelco, Inc., or Sigma Chemical
Company, St. Louis, Missouri. Solvents were of the highest
grades of purity. Chloroform and petroleum ether were redis-
tilled for use. Thin layer plates were from Applied Science
(Absorbosil 5) or Analtech, Inc. (Silica Gel H or G).
Results
Histological studies
Fifteen minutes of ischemia alone resulted in the swelling of
proximal tubular cells and organelles, including bulbous swell-
ing of the brush border. By 2 and 24 hr of blood reflow, the
histology of the kidney was quite normal, indicating reversi-
bility of the ischemic injury. In contrast, 60 mm of ischemia
resulted in changes that were persistent. At 2 hr, there was ex-
tensive damage to the brushborder microvilli, with the forma-
tion of numerous membrane-bounded blebs. This caused neph-
ron obstruction in the majority of tubules as reported before
[12]. By 24 hr, the entire proximal tubule was necrotic.
Biochemical studies
Free fatty acids. Ischemia induced increases of all unesteri-
fled (free) fatty acids in the tissue; this progressed with time
(Table 1). The percentile increments for polyunsaturated fatty
acids (18:2, 20:4, and 22:6) were greater than the increase ob-
served for saturated and monoenoic FFA (16:0, 18:0, 18:1).
The rate of increase in FFA was slower after the first 15 mm
of ischemia. When kidneys that had been rendered ischemic af-
ter prior washout of the vasculature with a blood-free physi-
ological solution were examined, virtually similar accumula-
tion of free fatty acids was seen to occur (as described above
for ischemic kidneys in vivo) when compared to appropriate
controls (Table 2).
During the 2 hr of blood reflow following ischemia, tissue
FFAs declined to lower levels (Table 1). In the case of the
milder injury (15 mm), the values were not significantly dif-
ferent from control rats. However, 2 hr following 60 mm of is-
chemia, the FFA levels remained at levels substantially above
normal (Table I).
Because FFA may be derived by the hydrolysis of triglycer-
ides and diglycendes in addition to phospholipid breakdown,
these glycerides were quantitated in ischemic tissue and ex-
pressed as micrograms of glyceride FFA per grams of dry
weight.
Triglycerides. These were measured in control kidneys and
in kidneys following 5, 15, or 60 mm of ischemia. Significant
reduction in triglyceride levels was observed only at 60 mm and
only for palmitic and stearic acid containing species (Table 3).
This decrease could not account for the net increase in FFA.
Thus, at 60 mm, the net increase of palmitic acid (441 tg/g dry
weight) could not be accounted for by the net decrease of 225
gIg dry weight of triglyceride palmitic acid. The same was
true for the other fatty acids. The percentile composition of dif-
ferent fatty acids in triglyceride in control and 60-mm ischemic
kidneys is also shown in Table 3. For reasons that are unclear,
triglyceride arachidonic acid showed a modest but significant
increment during ischemia.
Diglycerides. There was a steady increase in diglyceride con-
tent with increasing durations of ischemia (Table 4) when it was
measured as micrograms of diglyceride glycerol per gram of
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Table 1. Free fatty acid content in control kidneys and at various ischemic time intervals (/2gIg dry weight SEM)
15-mm Ischemia
I 20-mm Reflow
N—6 105 8b
60-mm Ischemia
120-mm Reflow
N=6 157± 9
Values not measurable are represented by a dash.
The values were not significant versus control, P > 0.05.
17± 4 22± 2
33± 8 31± 4b
71 7
178 26
67 4h 76 8 27 + 5b 28 3b
115±16 113±7 48± 6b 70± 11
Table 2. Free fatty acid content in control kidneys washed free of blood by perfusion with cold Krebs-Henseleit saline, and similarly perfused
kidneys thereafter made ischemic for 60 mm at 37°C (g/g dry weight SFM)
Table 3. Fatty acid content of triglycerides in control and ischemic kidneys and percent fatty acid composition (g/g dry weight 5EM)
Percent composition of triglyceride fatty acids
Control 38.4 11.1
60-mm Ischemia 27.1
The dash represents values not measurable.
P < 0.05.
dry weight by the chromotropic acid method. With the reflow
of blood, diglyceride content returned to normal levels after 15
mm of ischemia; on the other hand, diglyceride content re-
mained persistently elevated above control during reflow after
60 mm of ischemia.
Measured as diglyceride fatty acids, a similar trend of in-
crease in diglyceride content during ischemia was observed
(Table 5). When compared, the percentile composition of in-
dividual fatty acids in diglyceride from control and ischemic
kidneys showed no major differences. At least in the case of
arachidonic acid containing diglyceride species, the source for
hydrolysis was not triglyceride. Also, triglyceride breakdown
could not account for the major portion of stearoyl diglyceride
increase. When the results for diglyceride glycerol were ex-
pressed in molar amounts and compared to similarly ex-
pressed values from the gas chromatographic measurements, it
16:0
Palmitic
78± 5
18:0
Stearic
55± 2
18:1
Oleic
18:2
Linoleic
20:4
Arachidonic
60±4
72± 6 73-4-5h
Kidney group
Control
N= 7
Ischemia
5 mm
N=5 107± 75
Ischeniia
15 mm
N=5 244± 17 180± 9 106±6
lschemia
60 mm
N=5 519÷29 358±19 217±5
22:6
Docosahexaenojca
121 12
269 29
20 3
47 8
Kidney
group
16:0
Palmitic
18:0
Stearic
18:1
Oleic
18:2
Linoleic
14 I
255 17
20:4
Arachidonic
27 3
384 42
22:6
Docosahexaenoic
57 S
Control
(N = 3)
Ischemia
60 mm
(N = 3)
97 13
645 24
64
333
3
21
6l
229
5
17
a The dash represents values not measurable.
16:0 18:0 18:1 18:2 20:4 22:6
N — 3 Palmitic Slearic Oleic Linoleic Arachidonic Docosahexaenoic°
Control 415 21 120 11 233 68 254 62 50 2 9 2
5 mm 429 4 116 It) 251 28 201 15 100 13
15 mm 387 + 7 94 + 2 219 5 209 10 87 ÷ 2
60 mm 190 + 38 64 + 7 184 + 39 181 + 46 83 75
9.1
21.6 23.5 4.6
26.2 25.8 11.8
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Table 4. Diglycerides measured as glycerol (gIg dry weight SEM)
N = 7 Control 20 0.9
N = 7 5-mm lschemia 36 0.8
N = 5 15-mm Ischemia 64 2.5
N = 6 60-mm lschemia 83 1.9N 6 15-mm lschemia + 120-mm Reflow 20 1"
N = 6 60-mm Ischemia + 120-mm Reflow 27 I
a The value was not significant versus control.
became obvious that we were underestimating diglyceride con-
tent by the glycerol method. Despite this methodological prob-
lem, the results clearly reflected the patterns of change in
diglyceride content and paralleled the changes observed by gas
chromatographic measurement.
Phospholipids. Total phospholipid phosphorus in control rats
was 5.73 mg P/g dry weight. The values obtained at 15 mm of
ischemia, and 15-mm ischemia followed by 2 hr of reflow were
5.70 0,12 and 5.83 0.16mg Pig dry weight of tissue, re-
spectively; the values were not different from the control rats.
After 60 mm of ischemia the phospholipid content was 5.32
0.1 mg Pig dry weight, a decrease of 7% (P <0.01). After 2 hr
of blood reflow, the phospholipid content remained depressed
at 5.31 0.12 Pig dry weight. Tissue content of individual
phospholipids during and after ischemia are shown in Tables 6
and 7. By 15 mm of ischemia, there were no measurable
changes in the tissue content of major phospholipids (sphin-
gomyelin, phosphatidylinositol, phosphatidylserine, phosphati-
dyicholine, phosphatidylethanolamine, diphosphatidylglyc-
erol); in contrast, lysophosphatidyl choline, and phosphatidic
acid showed significant increase. A trend toward an increase in
lysophosphatidylethanolamine was also seen, but this did not
reach significance. After 2 hr of blood reflow following 15 mm
of ischemia, phosphatidylinositol, but not other major
phospholipids, showed a significant decrease. The values for
lysophosphatidylcholine and lysophosphatidylethanolamine re-
turned to control values, but phosphatidic acid remained el-
evated. In separate studies, lysophosphatidyicholine, lysophos-
phatidylethanolamine and phosphatidic acid were found to be
elevated as early as 5 mm after the induction of ischemia (data
not shown).
Sixty minutes of ischemia resulted in decreases of phosphati-
dylinositol (16%) and phosphatidylcholine (13%). A trend
toward a decline, not reaching significance, was seen for other
phospholipids also (Table 7). Phosphatidylcholine accounted
for nearly 50% of the decline in total phospholipids. Although
lysophospholipids were increased at the end of 15 mm of is-
chemia, they were within the normal range at 60 mm. Phospha-
tidic acid remained elevated to 53% above the control values.
Major phospholipids remained depressed at 2 hr of blood re-
flow to the same extent observed at the end of ischemia with-
out reflow (Table 7). Lysophosphatidylcholine and phospha-
tidic acid, on the other hand, showed significant elevations at
2 hr of blood reflow.
Cytotoxicity of FFA
The morphology of control proximal tubule cells in primary
explant culture is shown in Figure 1. Arachidonic, linoleic, and
oleic acids (165 /LM) caused marked cytotoxic effects when
they were applied to cells in the absence of albumin (Fig. 2 A
and B). Within 10 mm, treated cells exhibited bulbous expan-
sions of their plasma membranes, devoid of cell organelles
("blebs"). These structures were best visible in the plane of fo-
cus above the apical plasma membrane (Fig. 2B). Blebbing was
most marked with arachidonic acid (>75% cells blebbed),
intermediate with linoleic acid, and least with oleic acid (z=25%
cells blebbed). Treated cells also showed alterations in the op-
tical properties of their cytoplasm with increased granularity
and light scattering. By 30 mm of exposure, 100% of cells
treated with all three fatty acids showed loss of viability as in-
dicated by loss of ability to exclude trypan blue. Cells treated
with stearic acid or ethanol alone without Ca+ + (control) were
indistinguishable from each other and showed occasional bI-
ebbed cells (10%); otherwise, normal morphology and no loss
of viability were exhibited. The effects of arachidonic acid
were examined also at concentrations of 82.5 and 33 tM. Both
concentrations produced extensive blebbing within 10 mm and
cell death at 30 mm. Inclusion of albumin in the medium had
significant impact on the cytotoxic effects of added arachi-
donic acid. Albumin (130 riM) protected fully against cell death
induced by 82.5 M arachidonic acid. Plasma membrane bleb-
bing was reduced but was not abolished by albumin; approxi-
mately 25% of the cells still showed blebbing. These results are
similar to those obtained by Corr et al [23], who found that
BSA protected against, but did not abolish, the deleterious ef-
fects of added lysophosphatidylcholine on cardiac muscle
fibers.
Discussion
The results indicate that ischemia produces major perturba-
tions in the metabolism of renal cortical lipids. The cellular lo-
cations of these changes were not shown. However, prior mor-
phological studies have shown that the proximal tubule, par-
ticularly the S3 segment, is a major target for ischemic injury;
within each cell, injury is most severe in the brush border [12,
13, 15, 16]. Incorporation of '4C-choline into the brushborder
membrane phosphatidylcholine is accelerated during blood re-
flow following ischemia [1, 2]. These considerations suggest
that the lipid changes that we have observed take place, in
part, in the proximal tubule brushborder membrane.
Source of lipid breakdown products
Elevations of free fatty acids, lysophosphatidylcholine, and
diglycerides took place both in kidneys made ischemic in vivo
and in kidneys that had been perfused free of blood prior to is-
chemia. Because energy sources are depleted during ischemia
[24, 25], de novo synthesis of these products would not occur.
Therefore, breakdown of endogenous lipids explains the accu-
mulation of free fatty acids, lysophosphatidyicholine, and
diglycerides during ischemia. Declines in triglycerides, seen at
60 mm of ischemia, were confined to species containing pal-
mitic acid and stearic acid only, and were insufficient to ac-
count for the accumulation of free fatty acids and diglycerides
of diverse species. At the same time, declines of phospholipids
were sufficient to account for the measured increases in lipid
breakdown products. Our failure to show decreases of
phospholipids at 15 mm may be explained by insensitivity of
the measuring technique. Our studies do not reveal whether
phospholipid breakdown occurs at "normal" rates (that is, at
preischemic levels) or accelerated rates during ischemia. In-
Control
N= 7 722±17 287±4 366± 8 1904±28 1560±27 424± 7 42±2 10±2 17±1
15-mm Ischemia
N= 5 704±15 282±9 381 16 1860 63 1548 51 432 8 55 3 18±2 46±3
15-mm Ischemia
I 20-mm Reflow
N—6 730±35 237±8a 369 15 1940 64 1678 59 433 16 40 2 11±1 48±5a
Abbreviations: SPH, sphingomyelin; P1, phosphatidylinositol; PS, phosphatidylserine; PC, phosphatidylcholine; PE, phosphatidylethanola-
mine; DPG, diphosphatidylglycerol; LPC, lysophosphatidyicholine; LPE, lysophosphatidylethanolamine; PA, phosphatidic acid.
"P < 0.005 vs. control.
Table 7. Mean absolute values (g Pig dry weight 5EM) for the individual phospholipids in the control group, after 60 mm of ischemia and
after 60 mm of ischemia followed by 120 mm of reflow
SPH P1 PS PC PE DPG LPC LPE PA
Control
N = 7 722 17 287 4 366 8 1904 28 1560 27 424 7 42 2 10 2 17 1
60-mm Ischemia
N = 6 633 25 241 10" 349 22 1648 39" 1462 48 378 17 44 2 9 3 26 3"
60-mm lschemia
120-mm Reflow
N = 6 660 20 253 6 335 12 1626 45" 1393 43 385 13 57 3" 13 2 45 1"
Abbreviations are the same as those used in Table 6.
"P < 0.005 vs. control.
b P < 0.05 vs. control.
creased tissue levels of lipid breakdown products may occur as
a consequence of imbalance between their generation and dis-
posal. Thus, phospholipids may be hydrolyzed at "normal"
rates, but further degradation or reutilization of breakdown
products may be inhibited by disease. Because ischemia will
result in cessation of synthetic activity, a slow decline of
phospholipids and progressive accumulation of breakdown
products may result, which would be consistent with the re-
sults of our study. However, the possibility that there is an
"activation" of phospholipases, resulting in accelerated break-
down, as suggested for the liver [41, needs exploration. In this
context, the following considerations seem important. (1) In-
creases of lysophosphatidylcholine and free fatty acids early af-
ter ischemia suggest the action of enzyme(s) of the phospho-
lipase A class. At this time (15 mm), a decrease in the parent
compound, phosphatidylcholine, could not be shown. Para-
doxically, lysophosphatidylcholine declined to normal levels at
I hr, but became elevated again at 2 hr after blood reflow; at
both time intervals, phosphatidylcholine showed declines. Our
best explanation for these findings is that there is an imbalance
between the rates of degradation of phosphatidylcholine ver-
sus lysophosphatidylcholine early after isehernia [261 and that
an equilibrium is reached with continued ischemia. With blood
reflow after irreversible injury, there is again a disequilibrium.
More detailed investigations of the kinetics of action of
phospholipase A and lysophospholipases will be required to
throw light on this problem. Similar considerations apply to el-
evations of free fatty acids. Normal cells maintain very low 1ev-
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Table 5. Fatty acid content of diglycerides (jtgig dry weight 5EM) and percent composition of diglyceride fatty acids
Palmitic
N = 3 16:0
Stearic
18:0
Oleic
18:1
Linoleic
18:2
22÷ 1
46± 8
69±18
106 14
Arachidonic
20:4
70± 2
107±26
139±22
170 13
Docosahexaenoic
22:6
10±3
13±3
15±4
16 I
32.7
34.7
35.4
36.4
25.6
26.6
24.2
20.6
Control 115 5 90 7 45 + 4
5-nun lschemia 197 23 151 29 53 3
15-mm Ischemia 259 55 177 23 72 13
60-minlschemia 313 -- 15 178 4 78 2
Percent composition of fatty acids in diglyceride
Control
5-mm Ischemia
15-mm Ischemia
60-mm Ischemia
Table 6. Mean absolute values (zg Pig dry weight SEM) for the individual phospholipids in the control group, after 15 mm of ischenuia and
after IS mm of ischemia followed by 120 mm of reflow
12.9
9.4
9.8
9.0
6.1
8.1
9.4
12.3
19.8
18.8
19.0
19.7
2.8
2.3
2.1
1.9
SPH P1 PS PC PE DPG LPC LPE PA
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Fig. 1. Control proximal tubule cells in primary explant culture. (Phase
contrast, >< 210)
Fig. 2. A Proximal tubule cells as in Figure 110 mm after exposure to
33 /SM (10 sg/ml) arachidonic acid. Notice marked granularity of cy-
toplasm, and formation of plasma membrane blebs (arrows). (Phase
contrast, x 210) B The same cell field as in A, the plane of focus being
shifted above the apical plasma membrane. Numerous blebs are seen
(arrows). (Phase contrast, x 210)
els of free fatty acids through oxidative degradation, conver-
sion to other metabolites by cyclooxygenases and lipoxygen-
ases, and importantly, by rapid reacylation of lipid intermedi-
ates to form triglycerides or phospholipids. Due to the anoxia
and energy depletion, ischemic cells would be unable to per-
form these metabolic functions. Thus, in the face of a continu-
ous phospholipid degradation (normal or accelerated), rapid
and progressive accumulation of free fatty acids can be ex-
pected to result. (2) Increases of diglycerides (of the stearoyl
and arachidonoyl variety) and declines of phosphatidylinositol
suggest the action of enzyme(s) of the phospholipase C class.
Phosphatidylinositol specific phospholipase C occurs in the
kidney; the brushborder membrane is one location for this en-
zyme [271. As in the case of fatty acids, tissue accumulation of
diglycerides could be due, at least in part, to failure of mecha-
nisms which further metabolize diglycerides. (3) There was a
consistent increase of phosphatidic acid in ischeinic kidneys.
We have no explanation for this increase except to suggest that
it might be due to action of a phospholipase D, known to oc-
cur in the kidney [281.
Persistence of the lipid defect during blood reflow after
ischemia
Alterations of phosphatidyicholine metabolism, free fatty ac-
ids and diglycerides persisted into the reflow period only after
60 mm of ischemia. Persistence of these lipid alterations cor-
related with the occurrence of progressive membrane damage
during this period. Thus, altered lipid metabolism and mem-
brane lipid composition may be a determinant of membrane
damage (see below). Not explained, however, are the altera-
tions in phosphatidylinositol and phosphatidic acid that per-
sisted into the reflow period, even after 15 mm of ischemia.
Tissue free fatty acid content was elevated during blood re-
flow, but well below the very high values reached toward the
end of the ischemic period (Table 1). In other experiments, it
could be shown that this decline occurred soon after blood re-
flow was permitted (data not shown). This drop is probably re-
lated to the trapping of tissue free fatty acids by plasma pro-
teins and "washout" from the kidney during reflow. This is
suggested by the studies of Hsueh and Needleman [3] who used
albumin as a "trap" to capture labelled fatty acids released by
perfused kidneys and heart under conditions of hormone stimu-
lation and transient ischemia. Thus, the free fatty acid values
measured by us during blood reflow are underestimates of the
rates of fatty acid release during this period.
Ischemic injury in other organs—lipid changes
Alterations comparable to those reported here have been
shown to occur during ischemia or anoxia in other organs, such
as liver, heart, and brain. The possible importance of
lysophospholipid generation in cardiac arrhythmogenesis dur-
ing ischemia has been stressed by Sobel et al [71, Corr et al
[23], and Snyder et al [29]. Lysophospholipid generation dur-
ing cardiac ischemia was also observed by Shaikh and Downar
[8]. Further, increases of free fatty acids occur after 2 hr of car-
diac ischemia [61. The increases were most pronounced for the
polyunsaturated linoleic and arachidonic aids. Pronounced re-
lease of fatty acids in the cardiac effluent occurs following re-
flow of perfusate after 5 mm of ischemia [31. Rapid and pro-
gressive increases of free fatty acids and diglycerides occur in
the ischemic brain; the percentile changes were most pro-
nounced for unsaturated fatty acids, particularly arachidonic
acid and docosahexaenoic aid (22:6), and for stearoyl, arachi-
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donoyl diglycerides [9, 10]. Thus, it would seem that lipid al-
terations of the type described are a general response to
ischemia.
Relevance to membrane injury
Alterations of lipid composition can cause membrane dys-
function. In the ischemic liver and myocardium, depletion of
phosphatidyicholine and phosphatidylethanolamine is associ-
ated with increased Ca+ + permeability and decreased glu-
cose-6-phosphatase activity [4, 5, 30, 31]. Degradation of car-
diolipin and increase of free fatty acids has been suggested to
be the cause of irreversible loss of mitochondrial function in is-
chemic rat kidneys FIJI.
Unesterified fatty acids, lysophospholipids, and diglycerides
are all membrane-active agents with detergent properties. They
have been implicated in membrane fusion-fission events, the in-
hibition of enzymes including Na+, K+ activated ATPase, the
disruption of the cytoskeleton, and the causation of membrane
lysis by detergent action [32—37]. Accumulation of lysophos-
pholipids during cardiac ischemia is thought to be causative of
malignant dysrhythmias [7, 23, 31]. Small amounts of
lysophosphatidyicholine caused electrophysiological changes
in sheep and canine Purkinje fibers [38, 391. Increased concen-
tration of diglyceride in the erythrocyte membrane is related to
changes in membrane configuration and bleb formation [35,
36]. Unsaturated fatty acids in particular seem to have marked
perturbing effects [32—34, 37]. In agreement, we have shown
here marked cytotoxicity of unsaturated, but not saturated
fatty acids when added to cultures of proximal tubule cells.
Virtually identical results were obtained by us in LLC-PKJ
cells; a proximal tubule-like cell line was derived from pig kid-
neys (unpublished observations). The changes included the for-
mation of plasma membrane-derived vesicles in large num-
bers, similar to those that have been seen in the ischemically
injured kidney, and eventual necrosis of the cell. We have not
yet tested the cytotoxic potential of lysophospholipids in cul-
tured cells.
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